vimarsana.com

Latest Breaking News On - Investor relations corp development - Page 1 : vimarsana.com

Bruker : Launches timsTOF Ultra Mass Spectrometer with Transformative Sensitivity, 300 Hz PASEF MS/MS, and VistaScan™ for Enhanced dia-PASEF® 4D-Proteomics™

Bruker Launches timsTOF Ultra Mass Spectrometer with Transformative Sensitivity, 300 Hz PASEF MS/MS, and VistaScan™ for Enhanced dia-PASEF® 4D-Proteomics™ . | June 5, 2023

United statesNordrhein westfalenFritz schweikartFabian cosciaStefan tenzerErinh seeleyBruker proteoscapePetra schefferKarl mechtlerChristof lenzBruker paMukul midhaResearch scientistJohannes gutenberg university mainzBruker corporation nasdaqTechnical university munich

Bruker Corporation: Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers

New strategic partnership aims to broaden access to Biognosys' leading CRO services and Spectronaut® software tools for unbiased proteomics and epiproteomics Expected to benefit proteomics

United statesBiognosys truetargetRohan thakurRuedi aebersoldYves serroenPetra schefferBruker daltonics marketing communicationsBruker corporation nasdaqInvestor relations corp developmentSwitzerland based biognosysBusiness wireOliver rinnerBruker life science mass spectrometryBruker corporationExecutive officeDaltonics marketing communications

Investegate |Biognosys AG Announcements | Biognosys AG: Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers

Investegate announcements from Biognosys AG, Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers

United statesBiognosys truetargetRohan thakurRuedi aebersoldYves serroenPetra schefferBruker daltonics marketing communicationsServices for global biopharmaBruker corporation nasdaqInvestor relations corp developmentBruker form partnership for advanced proteomicsBruker form partnershipAdvanced proteomicsGlobal biopharmaBruker corporationOliver rinner

Biognosys AG: Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers

New strategic partnership aims to broaden access to Biognosys' leading CRO services and Spectronaut® software tools for unbiased proteomics and epiproteomicsExpected to benefit proteomics research, disease

United statesBiognosys truetargetRohan thakurRuedi aebersoldYves serroenPetra schefferBruker daltonics marketing communicationsBruker corporation nasdaqInvestor relations corp developmentBruker corporationOliver rinnerBruker life science mass spectrometryExecutive officer

Bruker Corporation: Bruker is Ushering in the Age of Spatial Single-Cell Metabolomics

Novel unbiased, in situ Spatial Single-Cell Metabolomics (SSCM) enables high-throughput metabolic tissue characterization with single-cell resolution New 5 µm microGRID technology for timsTOF

Baden wübergPetra schefferTheodore alexandrovMolecular medicine partnership unitBioinnovation instituteInternational conference of the metabolomics societyBruker daltonics marketing communicationsBiostudio faculty of the bioinnovation instituteBruker corporation nasdaqInvestor relations corp developmentSpatial single cell metabolomicsPredict proInternational conferenceMetabolomics societyBruker corporationMetabolomics core facility

vimarsana © 2020. All Rights Reserved.